Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 5
1999 12
2000 11
2001 14
2002 12
2003 12
2004 12
2005 8
2006 10
2007 10
2008 14
2009 11
2010 13
2011 13
2012 26
2013 26
2014 27
2015 35
2016 36
2017 40
2018 30
2019 40
2020 40
2021 39
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

424 results
Results by year
Filters applied: . Clear all
Page 1
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Boorjian SA, et al. Among authors: bivalacqua tj. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27. Lancet Oncol. 2021. PMID: 33253641 Free PMC article. Clinical Trial.
Pathophysiology of erectile dysfunction.
Matsui H, Sopko NA, Hannan JL, Bivalacqua TJ. Matsui H, et al. Among authors: bivalacqua tj. Curr Drug Targets. 2015;16(5):411-9. doi: 10.2174/138945011605150504114041. Curr Drug Targets. 2015. PMID: 25950641 Review.
Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.
Hoffman-Censits JH, Lombardo KA, Parimi V, Kamanda S, Choi W, Hahn NM, McConkey DJ, McGuire BM, Bivalacqua TJ, Kates M, Matoso A. Hoffman-Censits JH, et al. Among authors: bivalacqua tj. Appl Immunohistochem Mol Morphol. 2021 Sep 1;29(8):619-625. doi: 10.1097/PAI.0000000000000938. Appl Immunohistochem Mol Morphol. 2021. PMID: 33901032 Free PMC article.
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.
Steinberg RL, Thomas LJ, Brooks N, Mott SL, Vitale A, Crump T, Rao MY, Daniels MJ, Wang J, Nagaraju S, DeWolf WC, Lamm DL, Kates M, Hyndman ME, Kamat AM, Bivalacqua TJ, Nepple KG, O'Donnell MA. Steinberg RL, et al. Among authors: bivalacqua tj. J Urol. 2020 May;203(5):902-909. doi: 10.1097/JU.0000000000000688. Epub 2019 Dec 10. J Urol. 2020. PMID: 31821066
In Reply.
Brennen WN, Schweizer MT, Wang H, Bivalacqua TJ, Partin AW, Lim SJ, Chapman C, Abdallah R, Levy O, Bhowmick NA, Karp JM, De Marzo A, Isaacs JT, Denmeade SR. Brennen WN, et al. Among authors: bivalacqua tj. Stem Cells Transl Med. 2019 Jul;8(7):739-740. doi: 10.1002/sctm.19-0068. Epub 2019 Mar 29. Stem Cells Transl Med. 2019. PMID: 30925030 Free PMC article. No abstract available.
Reply by Authors.
Harris TGW, Manyevitch R, Wu WJ, Leto Barone AA, Bivalacqua TJ, Burnett AL, Gearhart JP, Redett RJ 3rd. Harris TGW, et al. Among authors: bivalacqua tj. J Urol. 2021 Mar;205(3):887. doi: 10.1097/JU.0000000000001404.03. Epub 2020 Dec 31. J Urol. 2021. PMID: 33393832 No abstract available.
Neurohumoral features of myocardial stunning due to sudden emotional stress.
Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Wittstein IS, et al. Among authors: bivalacqua tj. N Engl J Med. 2005 Feb 10;352(6):539-48. doi: 10.1056/NEJMoa043046. N Engl J Med. 2005. PMID: 15703419 Free article.
Urinary Tissue Engineering: Challenges and Opportunities.
Singh A, Bivalacqua TJ, Sopko N. Singh A, et al. Among authors: bivalacqua tj. Sex Med Rev. 2018 Jan;6(1):35-44. doi: 10.1016/j.sxmr.2017.08.004. Epub 2017 Oct 21. Sex Med Rev. 2018. PMID: 29066225 Review.
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer.
Singh AK, Praharaj M, Lombardo KA, Yoshida T, Matoso A, Baras AS, Zhao L, Srikrishna G, Huang J, Prasad P, Powell JD, Kates M, McConkey D, Pardoll DM, Bishai WR, Bivalacqua TJ. Singh AK, et al. Among authors: bivalacqua tj. Nat Commun. 2022 Feb 15;13(1):878. doi: 10.1038/s41467-022-28509-z. Nat Commun. 2022. PMID: 35169141 Free PMC article.
Editorial Comment.
Kates M, Bivalacqua TJ. Kates M, et al. Among authors: bivalacqua tj. J Urol. 2018 Nov;200(5):1011-1012. doi: 10.1016/j.juro.2018.05.157. Epub 2018 Jul 29. J Urol. 2018. PMID: 30063891 No abstract available.
424 results